Multiple Sclerosis :: Betaferon delays disability progession after multiple sclerosis attack

Patients treated with Betaferon? (interferon beta-1b) shortly after their first clinical MS event or ?attack? showed a 40 percent lower risk of developing confirmed disability when compared to patients in whom treatment was delayed. The results ? which were fast-tracked and published in The Lancet today ? provide the first controlled evidence that delaying Betaferon? treatment has an effect on later accumulation of disability. No other MS therapy has demonstrated this effect in this early patient population.

Tuberculosis :: TB vaccine could provide improved protection against tuberculosis

Using a novel approach, researchers at the Albert Einstein College of Medicine of Yeshiva University have developed a prototype vaccine against tuberculosis (TB) that works better in animal models than the only TB vaccine now available. In this era of multi-drug resistant TB and growing numbers of people with active TB due to coinfection with HIV, the advance could herald a needed breakthrough against one of the world?s leading killers.

Heart Disease :: Shorter heart health programs just as effective in saving lives

Secondary prevention programs for coronary heart disease that contain less than 10 hours contact with health professionals and those provided by family doctors are just as effective in saving lives as more expensive, longer and more specialized hospital-based alternatives, according to cardiovascular researchers at the University of Alberta in Edmonton, Canada.

Heartburn :: Cognitive impairment link found in older adults taking popular stomach acid medications

Long-term use of histamine2 receptor antagonists (H2A), one class of drugs that blocks stomach acid, may be associated with cognitive impairment in older African-American adults. According to an Indiana University School of Medicine and Regenstrief Institute study published in the August issue of the Journal of the American Geriatrics Society, the risk for showing signs of cognitive impairment is 2.5 times greater for patients using these medications long-term.

Brain :: Music moves brain to pay attention

Using brain images of people listening to short symphonies by an obscure 18th-century composer, a research team from the Stanford University School of Medicine has gained valuable insight into how the brain sorts out the chaotic world around it.

Homeopathy :: The memory of water is a reality

A special issue of the journal Homeopathy, journal of the Faculty of Homeopathy and published by Elsevier, on the ?Memory of Water? brings together scientists from around the world for the first time to publish new data, reviews and discuss recent scientific work exploring the idea that water can display memory effects.

Glaucoma :: New treatment for glaucoma shows promise in laboratory

Iowa State University researchers have developed a new technique that successfully treated rats for blindness caused by glaucoma. Their experimental treatment will be used on canine patients in the next year. If successful, it is expected to move to human trials.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack